Multi-Stage Cannabinoid Formulation for Controlled Release Timing
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current cannabinoid compositions lack controlled bioavailability and delayed onset, leading to unpredictable therapeutic effects and potential adverse effects due to the challenges in administering multiple psychoactive compounds simultaneously with pre-programmed onset and offset times.
Innovation Solution
A multi-stage formulation comprising two or more compositions with different release profiles, where active agents such as cannabinoids and analgesics are staged for release at various times, using techniques like immediate, controlled, or sustained release, and bioavailability enhancers like N-acylated fatty amino acids, to manage pain and therapeutic effects.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If multiple psychoactive compounds are administered simultaneously with pre-programmed onset and offset times, then controlled bioavailability and delayed onset are achieved, but the complexity of formulation and manufacturing increases
Solution Approach 1:
The formulation is divided into multiple distinct compositions, each with specific cannabinoids and bioavailability enhancers, that are staged for release at different times. This segmentation allows independent optimization of each composition's release characteristics while maintaining overall system control.
Solution Approach 2:
Multiple compositions are nested within a single dosage form structure, with inner compositions protected by outer coatings or matrices. This nested arrangement enables sequential release of different cannabinoid combinations at predetermined times without requiring separate administration.
2Adaptability or versatility
If multiple psychoactive compounds are administered simultaneously, then comprehensive therapeutic coverage is achieved, but the difficulty of detecting and measuring individual compound effects increases
Solution Approach 1:
By segmenting the formulation into distinct compositions with different cannabinoid profiles and release timing, the patent enables selective detection and measurement of individual compound effects. Each composition can be optimized for specific therapeutic endpoints, making it easier to monitor and measure the intended effects of each stage.
3Speed
If immediate release of all compositions is used, then rapid onset is achieved, but the inability to delay onset leads to adverse effects from overconsumption
Solution Approach 1:
The formulation employs periodic release of different compositions at predetermined time intervals. This periodic action ensures that cannabinoids are released in controlled batches rather than all at once, maintaining appropriate onset speed for each stage while preventing overconsumption through built-in temporal separation of releases.
Solution Approach 2:
The formulation includes preliminary coatings or matrices that must be degraded or eroded before inner compositions are released. This preliminary action creates a built-in delay mechanism that prevents immediate release of all compounds, thereby avoiding adverse effects from overconsumption while still providing rapid onset for each individual release stage.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The multi-stage formulation allows for controlled initiation and management of therapeutic effects, enhancing bioavailability and safety by ensuring precise timing of drug action and minimizing adverse effects.
Implementation Method 1
One or more staged composition may comprise one or more bioavailability enhancers
Data Source
AI summary
The present disclosure provides a pharmaceutical composition for multi-stage release of psychoactive substances including cannabinoids. The pharmaceutical composition comprises two or more staged compositions having different release profiles or different release time such that the one or more active agents in each of the two or more staged compositions are released into the subject's blood stream at different time points.